课题基金 / 基金详情

PHASE I STUDY OF TAXOTERE IN PEDIATRIC PATIENTS WITH NEOPLASTIC DISEASE

PHASE I STUDY OF TAXOTERE IN PEDIATRIC PATIENTS WITH NEOPLASTIC DISEASE
泰索帝治疗儿科肿瘤患者的 I 期研究
批准号:
5219446
负责人:
JAMES A WHITLOCK
金额:
$0.0万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

JAMES A WHITLOCK的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Briefly, taxotere is a novel semisynthetic analogue of taxol which is prepared from a precursor extracted from the needles, rather than the bark of Taxus brevifolia. Thus, the supply of taxotere is significantly more stable and predictable than that of the parent compound Taxol. In vitro experiments have shown that taxotere, like taxol, induces the formation of microtubule bundles that are stable in the presence of depolymerizing agents such as Ca and low temperature. This results in cytotoxicity by blocking cells at either the G2 or M phase of the cell cycle. Taxotere has been shown to be slightly more active than taxol in promoting tubulin polymerization. In addition, preclinical studies have demonstrated that taxotere has superior in vivo activity versus Taxol in some murine tumor models.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PROTOCOL REVIEW & MONITORING SYSTEM SCIENTIFIC REVIEW COMMITTEE
  • 批准号:
    6990196
  • 项目类别:
  • 资助金额:
    $8.77万
  • 财政年份:
    2004
  • 负责人:
    JAMES A WHITLOCK
  • 依托单位:
Core--Clinical trial protocol review and monitoring system
  • 批准号:
    6395769
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    1999
  • 负责人:
    JAMES A WHITLOCK
  • 依托单位:
Core--Clinical trial protocol review and monitoring system
  • 批准号:
    6396878
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    1999
  • 负责人:
    JAMES A WHITLOCK
  • 依托单位:
PHASE I TRIAL OF D1694, AN INHIBITOR OF THYMIDYLATE SYNTHASE
  • 批准号:
    6115602
  • 项目类别:
  • 资助金额:
    $3.64万
  • 财政年份:
    1998
  • 负责人:
    JAMES A WHITLOCK
  • 依托单位:
海外基金